|
Sc-8336-50 (sn (b)(6).\
\
investigation result:\
the device was not returned to boston scientific for analysis.\
\
device history record:\
a review of the device history record (dhr) was conducted.The records indicate that the device met all applicable acceptance criteria and release requirements prior to distribution.No manufacturing-related nonconformances or deviations were identified during the review that could be associated with the reported event.\
\
labeling review:\
a labeling review did not reveal any anomalies as it states: tissue reaction to implanted materials can occur.In some cases, the formation of reactive tissue around the lead in the epidural space can result in delayed onset of spinal cord compression and neurological/sensory deficit, including paralysis.Time to onset is variable, possibly ranging from weeks to years after implant and skin erosion at the ipg site can occur over time.Labeling also states: during the two weeks following surgery, it is important that patients use extreme care so that appropriate healing will secure the implanted components and close the surgical incisions.\
\
investigation conclusion:\
based on a thorough review of the reported complaint, boston scientific has assigned an investigation conclusion code of cause not established.\
\
sc-1232 (sn (b)(6)\
\
investigation result:\
the device was not returned to boston scientific for analysis.\
\
device history record:\
a review of the device history record (dhr) was conducted.The records indicate that the device met all applicable acceptance criteria and release requirements prior to distribution.No manufacturing-related nonconformances or deviations were identified during the review that could be associated with the reported event.\
\
labeling review:\
a labeling review did not reveal any anomalies as it states: skin erosion at the ipg site can occur over time.Possible surgical procedural risks are: temporary pain at the implant site, infection, cerebrospinal fluid (csf) leakage and, although rare, epidural hemorrhage, seroma, hematoma and paralysis.\
\
risk review:\
a risk review was completed and confirmed that the event of dehiscence was defined in the risk documentation.This event type has been accounted for during product risk analysis to support acceptable risk benefit for the product.\
\
investigation conclusion:\
based on a thorough review of the reported complaint, boston scientific has assigned an investigation conclusion code of cause not established.\
\
additional suspect medical device component involved in the event:\
model number/catalog number: sc-1232\
serial number: (b)(6)\
batch/lot number: 809400\
model/catalog description: wavewriter alpha 32 ipg kit\
unique identifier (udi) #:(b)(4).
|